🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was the cross-sectional study to assess the period prevalence of IOI i...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-07-15
Trial ID
NCT05146687
Treatments Being Tested
The purpose of this study is to generate additional safety and effectivenes...
Status
Completed
Location
Novartis Investigative Site
Start Date
2024-12-11
Trial ID
NCT05959304
Treatments Being Tested
The study is a prospective and retrospective, observational, single-arm, no...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2022-04-13
Trial ID
NCT05266495
Treatments Being Tested
The purpose of this study was to generate additional safety and effectivene...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-03-09
Trial ID
NCT05269966
Treatments Being Tested
RAZORBILL was an observational, multicenter, multinational, open-label, stu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-02-23
Trial ID
NCT04662944
Treatments Being Tested
Diabetic macular edema degeneration occur is a vision threatening condition...
Status
Unknown
Location
INMC
Start Date
2021-01-12
Trial ID
NCT04955171
Treatments Being Tested
The purpose of this extension study was to assess the safety and efficacy o...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-01-15
Trial ID
NCT03386474
Treatments Being Tested
BESRA is a national, multi-center, prospective, observational study to asse...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2021-11-19
Trial ID
NCT05112835
Treatments Being Tested
This study is a 60-week, two-arm, randomized, open-label, active-controlled...
Status
Completed
Location
Novartis Investigative Site
Start Date
2023-02-06
Trial ID
NCT05666804
Treatments Being Tested
This was a multicenter, open label study that is designed to evaluate the s...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-05-23
Trial ID
NCT03930641
Treatments Being Tested